Glenview Capital, CVS Health's major shareholder, plans to meet execs to propose a value enhancement plan amid recent struggles and a 22% share decline.

Glenview Capital, a major shareholder of CVS Health, intends to meet with executives to propose a plan aimed at enhancing the company's value, potentially signaling an activist campaign. CVS has struggled recently, facing a 22% share decline and three consecutive quarters of lowered guidance, largely due to challenges in its retail pharmacy and insurance sectors. The company plans to cut $2 billion in expenses as part of its response to these issues.

September 30, 2024
49 Articles

Further Reading